Nasdaq:US$16.04 (+0.07) | HKEX:HK$25.55 (+0.10) | AIM:£2.36 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor